Press release content from PR Newswire. The AP news staff was not involved in its creation.
EXACT THERAPEUTICS AS Announces Appointment of Dominic Moreland as Chief Financial Officer
April 7, 2021 GMT
OSLO, Norway and LONDON, April 7, 2021 /PRNewswire/ EXACT THERAPEUTICS AS (“EXACT-Tx” or the “Company”), a clinical stage precision medicine company utilizing Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today announced the appointment of Dominic Moreland as Chief Financial Officer who will be based at the London office of EXACT-Tx in White City.
“We are delighted to welcome Dominic to EXACT Therapeutics AS where his strong prior experience in both finance and operations in the biopharmaceutical sector, most recently as VP Finance at Autolus Therapeutic Plc, will be pivotal in driving forward our organization”, said Dr Rafiq Hasan, CEO of EXACT Therapeutics AS. “Dominic joins EXACT-Tx at an exciting time as we continue to expand our presence in
EXACT THERAPEUTICS AS Announces Appointment of Dominic Moreland as Chief Financial Officer prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare
January 20, 2021 GMT
OSLO, Norway and LONDON, Jan. 20, 2021 /PRNewswire/ EXACT THERAPEUTICS AS (“EXACT-Tx” or the “Company”), a clinical stage precision medicine company today announced a collaboration with GE Healthcare to develop an innovative ultrasound probe to be used in forthcoming studies using Acoustic Cluster Therapy (ACT®) across multiple disease conditions.
“We are delighted to collaborate with GE Healthcare, a leader in the field of diagnostic imaging and ultrasound. We look forward to working closely with GE Healthcare in developing an innovative ultrasound probe with the goal of enabling effective deployment of the ACT® therapeutic amplification platform across indications for our forthcoming phase II clinical development program”, said Dr Rafiq Hasan, CEO of EXACT Thera